Search results for "Highlights"


 
Results 141 - 150 of about 234 for "Highlights".
Sort by: Relevance | Newest | Oldest

Best practice advice offered for diagnosis, management of seronegative enteropathy

The American Gastroenterological Association said that diagnosis of seronegative celiac disease, the most common cause of seronegative enteropathy, can be complicated by misinterpretation of histological findings, insufficient serological testing, IgA deficiency, and premature initiation of a gluten-free diet.
https://gastroenterology.acponline.org/archives/2020/10/23/3.htm
23 Oct 2020

Rivaroxaban associated with increased risk for GI bleeding compared to other DOACs

A study in Iceland of direct oral anticoagulants (DOACs) found a higher risk for overall and major GI bleeding with rivaroxaban than with either apixaban or dabigatran.
https://gastroenterology.acponline.org/archives/2021/10/22/1.htm
22 Oct 2021

AASLD offers guidance on reproductive health and liver disease

Menopausal hormone therapy should not be used in women with decompensated liver function, Budd-Chiari syndrome, or hepatocellular adenomas, the American Association for the Study of Liver Diseases (AASLD) said, among other recommendations.
https://gastroenterology.acponline.org/archives/2020/09/25/2.htm
25 Sep 2020

Cannabis, cannabinoids didn't improve remission or inflammatory markers in IBD

A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
https://gastroenterology.acponline.org/archives/2020/07/24/3.htm
24 Jul 2020

CDC updates guidance on responding to health care exposures to HCV

The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
https://gastroenterology.acponline.org/archives/2020/08/28/2.htm
28 Aug 2020

PPIs in patients receiving anticoagulation may not reduce upper GI events

There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
https://gastroenterology.acponline.org/archives/2019/05/24/3.htm
24 May 2019

COVID-19 mRNA vaccines appear effective in patients with cirrhosis

A retrospective cohort study compared outcomes among U.S. veterans with cirrhosis who received at least one dose of an mRNA COVID-19 vaccine with those of a propensity-matched control group of unvaccinated patients at similar risk.
https://gastroenterology.acponline.org/archives/2021/07/23/1.htm
23 Jul 2021

Steroids may not be needed with anti-TNF induction in Crohn's disease

Rates of clinical remission and clinical response were 32.0% and 42.7%, respectively, in Crohn's disease patients receiving therapy with both corticosteroids and anti-tumor necrosis factor (TNF) agents and 35.5% and 46.8% in those receiving only anti-TNF agents, a systematic review and meta-analysis found.
https://gastroenterology.acponline.org/archives/2020/06/26/3.htm
26 Jun 2020

Liver cancer diagnosis delayed in almost half of veterans with cirrhosis

Failure to follow guidelines, diagnostic imaging without alpha-fetoprotein measurement, and diagnosis from an incidental finding were all associated with a delay of more than 60 days between a red flag for hepatocellular carcinoma and a diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/07/24/2.htm
24 Jul 2020

Specialty groups offer updated guidelines on care surrounding bariatric surgery

The update from endocrinology, obesity, surgery, anesthesiology, and nutrition experts covers perioperative nutritional, metabolic, and nonsurgical support of patients undergoing bariatric procedures.
https://gastroenterology.acponline.org/archives/2019/11/22/3.htm
22 Nov 2019

Result Page: Prev   10   11   12   13   14   15   16   17   18   19   Next